Insights

Women’s Health Expansion Daye’s mission to close the gender health gap and its trajectory toward endometriosis, PCOS, and menopause solutions signals opportunities to upsell integrated gynae health platforms, telemetry, and remote monitoring tools to healthcare providers and payers seeking comprehensive women’s health ecosystems.

Digital Health Ecosystem With plans to build a smartphone-based health monitoring ecosystem and a mobile-first approach, there is a compelling path to partner on data integration, AI-driven insights, patient engagement channels, and telehealth integrations for clinics and employers.

Scale & Enterprise Revenue in the multiple tens of millions range and a mid-size team indicate readiness for enterprise collaborations, white-label partnerships, and co-development deals with pharma, medtech, or healthcare platforms targeting gynae health.

Innovation & Compliance Daye’s history of product-led innovation (pain-relieving tampon with at-home diagnostics) paired with a tech stack including cloud, CD, and PWA suggests readiness for partnerships around regulatory-compliant digital health solutions, data security, and scalable cloud deployments.

Market Momentum A track record of helping tens of thousands of users and a clearly defined vertical focus in reproductive health present opportunities with employer benefits programs, insurance providers, and telemedicine partners seeking validated consumer-centric gynae health solutions.

Daye Tech Stack

Daye uses 8 technology products and services including Metabase, Prismic, Cloudflare, and more. Explore Daye's tech stack below.

  • Metabase
    Business Intelligence
  • Prismic
    Content Management System
  • Cloudflare
    Content Management System
  • Google Fonts API
    Font Scripts
  • Playwright
    Frameworks And Libraries
  • TweenMax
    Javascript Frameworks
  • PWA
    Miscellaneous
  • Cloudflare Bot Management
    Security

Daye's Email Address Formats

Daye uses at least 1 format(s):
Daye Email FormatsExamplePercentage
First@yourdaye.comJohn@yourdaye.com
82%
First.Last@yourdaye.comJohn.Doe@yourdaye.com
18%

Frequently Asked Questions

What is Daye's stock symbol?

Minus sign iconPlus sign icon
Daye is a publicly traded company; the company's stock symbol is NAVODAYENT.BO.

What is Daye's official website and social media links?

Minus sign iconPlus sign icon
Daye's official website is yourdaye.com and has social profiles on LinkedInCrunchbase.

How much revenue does Daye generate?

Minus sign iconPlus sign icon
As of July 2026, Daye's annual revenue is estimated to be $100M - $250M.

What is Daye's NAICS code?

Minus sign iconPlus sign icon
Daye's NAICS code is 92312 - Administration of Public Health Programs.

How many employees does Daye have currently?

Minus sign iconPlus sign icon
As of July 2026, Daye has approximately 114 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Operations Officer: A. P.Chief Technology Officer: E. C.Head Of Customer Care: S. D.. Explore Daye's employee directory with LeadIQ.

What industry does Daye belong to?

Minus sign iconPlus sign icon
Daye operates in the Public Health industry.

What technology does Daye use?

Minus sign iconPlus sign icon
Daye's tech stack includes MetabasePrismicCloudflareGoogle Fonts APIPlaywrightTweenMaxPWACloudflare Bot Management.

What is Daye's email format?

Minus sign iconPlus sign icon
Daye's email format typically follows the pattern of First@yourdaye.com. Find more Daye email formats with LeadIQ.

How much funding has Daye raised to date?

Minus sign iconPlus sign icon
As of July 2026, Daye has raised $17M in funding. The last funding round occurred on Oct 26, 2022 for $12M.

When was Daye founded?

Minus sign iconPlus sign icon
Daye was founded in 2017.
Daye logo

Daye

Public HealthEngland, United Kingdom51-200 Employees

Daye is a mid-sized, London, England-based startup focused on gynecological health within the public health sector. It began with the development of a tampon designed to relieve menstrual cramps, addressing a common issue for people who menstruate. After helping more than 75,000 women and AFAB individuals manage period pain, the company launched a second-generation tampon that supports at-home detection of vaginal infections, STIs, and HPV. In the next five years, Daye aims to expand into under-served gynecological conditions such as endometriosis, PCOS and menopause and build a smartphone-based health ecosystem.

Section iconCompany Overview

Stock Symbol
NAVODAYENT.BO
NAICS Code
92312 - Administration of Public Health Programs
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $17M

    Daye has raised a total of $17M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12Mas a series_a.

  • $100M - $250M

    Daye's revenue is estimated to be in the range of $100M - $250M

Section iconFunding & Financials

  • $17M

    Daye has raised a total of $17M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12Mas a series_a.

  • $100M - $250M

    Daye's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.